When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for depression, PTSD, anxiety, and other mental health conditions. So, what promise do they hold as therapeutics? Albert Garcia-Romeu, a researcher at John’s Hopkins University, joins Dr. Sanjay Gupta to talk about how psychedelics can alleviate mental suffering and what the path forward might look like.
Dr. Sanjay Gupta: How Storytelling Shapes Memory
The holidays are full of stories, laughter, and maybe a little disagreement. Ever try telling a story and hear someone say, “That’s not what happened!”? There’s actually science behind it. Dr. Signy…
Thought Leader: Sanjay Gupta
Peter Zeihan: The Russian Breakdown
Should the war in Ukraine result in a Russian loss, what will the future hold for Russia? Well, we know the road ahead for the…
Thought Leader: Peter Zeihan
Patrick McGee: How iPhones Helped Build China Into A Superpower
Dr. Elizabeth Economy sits down with Patrick McGee to discuss how Apple’s deep integration into China’s manufacturing ecosystem inadvertently helped build China into the industrial…
Thought Leader: Patrick McGee
Dr. Sanjay Gupta: How Storytelling Shapes Memory
Thought Leader: Sanjay Gupta
Dr. Sanjay Gupta: Why Haven’t We Cured the Common Cold?
Thought Leader: Sanjay Gupta
